Hemoglobin level as a predictor of clinical outcome in patients with ischemic stroke

Guo et al. investigated the association between hemoglobin at acute phase and clinical outcomes in patients with ischemic stroke [1]. The authors selected major disability and death at 3 months as the primary outcomes after stroke onset and events that were separately evaluated as the secondary outcomes. Adjusted odds ratios (ORs) (95% confidence intervals [CIs]) of the highest quartile of hemoglobin against the lowest quartile for the primary outcomes, major disability and death, were 1.38 (1.03–1.86), 1.49 (1.11–1.99), and 0.79 (0.41–1.52), respectively.

from Journal of the Neurological Sciences https://ift.tt/2T42SjE